Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, a potential ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with ...

ORLANDO - Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products with a market capitalization of $74 million, announced Monday that it has received a Notice of ...

The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...

The study is gathering the stories of survivors of abuse in "faith settings", who hope it could lead to a public inquiry. The Islands Safeguarding Children Partnership works with agencies to ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even ...

Liang Wenfeng, founder of DeepSeek, has exposed how China can build a cheaper, faster, and less power-hungry AI. Picture: Getty ...

It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids ...

The ability to retaliate makes deterrence work. Without it, a security crisis is likely to emerge. There are also reasons to doubt that an Iron Dome for America would even work. Defense ...